Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 151 Results

Title
Intervention Indication Therapeutic Area Year Actions
177Lu-PSMA-617 for metastatic castrationresistant prostate cancer - third line Lutetium (177Lu-PSMA-617; 177Lu-DOTA-tyr3-octreotate; Lutathera) Prostate cancer Male Reproductive Cancer 2020 View  |  Download
ABBV-951 for motor fluctuations in Parkinson’s disease ABBV-951 (fixed dose combination: Carbidopa; Levodopa) Parkinson's disease Neurology 2020 View  |  Download
Abemaciclib for early breast cancer – adjuvant treatment Abemaciclib (LY2835219; Verzenio; CC-115) Breast cancer Breast Cancer 2020 View  |  Download
Abilify MyCite (aripiprazole with sensor) for bipolar disorder and schizophrenia Aripiprazole (Abilify Mycite; Abilify; OPC-14597; Aristada; ALKS-9070) Bipolar disorder , Schizophrenia Mental and Behavioural Health 2020 View  |  Download
Abrocitinib for moderate to severe atopic dermatitis Abrocitinib (PF-04965842) Atopic dermatitis Dermatology 2020 View  |  Download
Aducanumab for mild cognitive impairment due to Alzheimer’s disease Aducanumab (BIIB037) Cognitive impairment Neurology 2020 View  |  Download
AMG 510 for KRAS G12c mutated metastatic non-small cell lung cancer - after prior standard therapy Sotorasib (AMG 510) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2020 View  |  Download
Anifrolumab for moderately to severly active, autoantibody-positive systemic lupus erythematosus Anifrolumab (MEDI546) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2020 View  |  Download
Asciminib for chronic myeloid leukaemia – chronic phase -third line Asciminib (ABL001) Chronic myeloid leukaemia (CML) Haematological Cancer and Lymphomas 2020 View  |  Download
ATB200/AT2221 for Late onset Pompe disease in adults and adolescents over 12 years – first line ATB200/AT2221 Pompe disease Endocrine Nutritional and Metabolic Disorders , Genetic Disorders 2020 View  |  Download
1 2 3 15 16
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications